Clinical Trials List
Protocol NumberGN41851
Completed
2020-12-01 - 2022-11-30
Phase III
Recruiting2
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yu-Wan Yang Division of Neurology
- Ching-Hua Lu Lu Division of Neurology
- Kang-Hsu Lin Division of Neurology
- 李英玄 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YA-FANG CHEN Division of Radiology
- HSUEH-WEN HSUEH Division of Neurology
- Chi-Chao Chao Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
734 participants
